OXYCODONE HCl 50 mg/1 mL MEDSURGE oxycodone hydrochloride 50 mg/1 mL solution for injection ampoule Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 50 mg/1 ml medsurge oxycodone hydrochloride 50 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Amitriptyline Hydrochloride 50 mg/ 5 ml Oral Solution Írsko - angličtina - HPRA (Health Products Regulatory Authority)

amitriptyline hydrochloride 50 mg/ 5 ml oral solution

pinewood laboratories ltd, - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline

Epilim Syrup Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

epilim syrup

sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: sorbitol; sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; saccharin sodium; brilliant scarlet 4r; purified water; sucrose; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

NEORAL CAPSULE Kanada - angličtina - Health Canada

neoral capsule

novartis pharmaceuticals canada inc - cyclosporine - capsule - 50mg - cyclosporine 50mg - immunosuppressive agents

RAN-CLARITHROMYCIN POWDER FOR SUSPENSION Kanada - angličtina - Health Canada

ran-clarithromycin powder for suspension

sun pharma canada inc - clarithromycin - powder for suspension - 250mg - clarithromycin 250mg - other macrolides

TARO-CLARITHROMYCIN POWDER FOR SUSPENSION Kanada - angličtina - Health Canada

taro-clarithromycin powder for suspension

taro pharmaceuticals inc - clarithromycin - powder for suspension - 250mg - clarithromycin 250mg - other macrolides

CELLCEPT mycophenolate mofetil 200mg/mL suspension bottle Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

cellcept mycophenolate mofetil 200mg/ml suspension bottle

roche products pty ltd - mycophenolate mofetil, quantity: 200 mg/ml - suspension - excipient ingredients: citric acid; xanthan gum; aspartame; methyl hydroxybenzoate; purified water; silicon dioxide; sorbitol; lecithin; sodium citrate dihydrate; flavour - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Epilim Liquid Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

epilim liquid

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 40 mg/ml;   - oral solution - 200 mg/5ml - active: sodium valproate 40 mg/ml   excipient: cherry flavour 17.40.0740 citric acid hyetellose ponceau 4r purified water saccharin sodium sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.

Klacid Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

klacid

viatris limited - clarithromycin 250mg;  ; clarithromycin 250mg - film coated tablet - 250 mg - active: clarithromycin 250mg   excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow   sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin active: clarithromycin 250mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol   hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow   sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.